Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature
L Nalotto, L Iaccarino, M Zen, M Gatto, E Borella… - Immunologic …, 2013 - Springer
In this paper, we report our experience with the use of rituximab (RTX) in the treatment of
refractory idiopathic inflammatory myopathies (IIM) and review the literature on this topic. Six …
refractory idiopathic inflammatory myopathies (IIM) and review the literature on this topic. Six …
[HTML][HTML] Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome
I Marie, S Dominique, A Janvresse, H Levesque… - Respiratory …, 2012 - Elsevier
OBJECTIVE: To report our experience using rituximab as therapy for refractory
antisynthetase syndrome (ASS)-associated interstitial lung disease. METHODS: We …
antisynthetase syndrome (ASS)-associated interstitial lung disease. METHODS: We …
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011
DE Furst, EC Keystone, J Braun… - Annals of the …, 2012 - ard.bmj.com
As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 13th Annual Workshop on Advances in …
treatment of rheumatic diseases met during the 13th Annual Workshop on Advances in …
Recent developments on treatment strategies and the prognosis of dermatomyositis: a review
V Isak, JL Jorizzo - Journal of Dermatological Treatment, 2018 - Taylor & Francis
Dermatomyositis is an autoimmune disease affecting both skin and muscle. Steroids are the
first line treatment. However, no consensus regarding dosing, length of treatment, tapering …
first line treatment. However, no consensus regarding dosing, length of treatment, tapering …
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
DE Furst, EC Keystone, J Braun… - Annals of the …, 2011 - ard.bmj.com
As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 12th Annual Workshop on Advances in …
treatment of rheumatic diseases met during the 12th Annual Workshop on Advances in …
Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids
Objective. Ciclosporin and MTX are used in idiopathic inflammatory myopathies (DM and
PM) when patients incompletely respond to glucocorticoids. Their effectiveness is unproved …
PM) when patients incompletely respond to glucocorticoids. Their effectiveness is unproved …
Dermatomyositis and polymyositis: from immunopathology to immunotherapy (immunobiologics)
SK Shinjo, FHC de Souza, JCB de Moraes - Revista Brasileira de …, 2013 - Elsevier
Idiopathic inflammatory myopathies (IIM), which include dermatomyositis (DM) and
polymyositis (PM), are chronic systemic diseases associated with high morbidity and …
polymyositis (PM), are chronic systemic diseases associated with high morbidity and …
Therapeutic approaches in myositis
R Aggarwal, CV Oddis - Current rheumatology reports, 2011 - Springer
The inflammatory myopathies are a heterogeneous group of diseases including
dermatomyositis, polymyositis, and inclusion body myositis. Few clinical trials have been …
dermatomyositis, polymyositis, and inclusion body myositis. Few clinical trials have been …
Inmunoglobulinas intravenosas: llave inmunomoduladora del sistema inmunológico
R Ramos-Medina, AL Corbí, S Sánchez-Ramón - Medicina Clínica, 2012 - Elsevier
The mechanisms of action of intravenous immunoglobulins (IVIG) are complex and mostly
reproduce those of the natural immunoglobulin G (IgG) in our organism. The therapeutic …
reproduce those of the natural immunoglobulin G (IgG) in our organism. The therapeutic …
Documentation of off-label use of biologics in Rheumatoid Arthritis
DE Furst, R Fleischman, J Kalden… - Annals of the …, 2013 - ard.bmj.com
The 'Updated Consensus Statement on Biological Agents for the Treatment of Rheumatic
Diseases' represents the consensus and efforts of a worldwide group of experts regarding …
Diseases' represents the consensus and efforts of a worldwide group of experts regarding …